Join us for an informative webinar examining the relative benefits and risks of kratom-derived products. This session will provide an overview of natural leaf kratom, mitragynine extracts, and isolated synthetic compounds (7-OH, mitragynine pseudoindoxyl, MGM-15/16), compare their pharmacologic profiles with traditional opioids, review available clinical and anecdotal data on potential risks and benefits, and discuss regulatory strategies aimed at reducing public health harms while preserving access to natural leaf kratom.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN: Overdose Prevention Engagement Network. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
